202 related articles for article (PubMed ID: 17617046)
21. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation.
Land W
Transplant Proc; 1994 Dec; 26(6):3169-71. PubMed ID: 7998106
[No Abstract] [Full Text] [Related]
22. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptors and graft rejection.
Liu G; Wu Y; Gong S; Zhao Y
Transpl Immunol; 2006 Jun; 16(1):25-31. PubMed ID: 16701173
[TBL] [Abstract][Full Text] [Related]
24. Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system.
Fox-Marsh A; Harrison LC
J Leukoc Biol; 2002 Mar; 71(3):401-9. PubMed ID: 11867677
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases.
Schaefer L
Curr Opin Pharmacol; 2010 Apr; 10(2):185-90. PubMed ID: 20045380
[TBL] [Abstract][Full Text] [Related]
26. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
Carstens J; Ozbay A; Tørring C; Hansen HE
Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
[TBL] [Abstract][Full Text] [Related]
27. Innate immunity's path to the Nobel Prize 2011 and beyond.
Wagner H
Eur J Immunol; 2012 May; 42(5):1089-92. PubMed ID: 22539282
[TBL] [Abstract][Full Text] [Related]
28. The mechanisms of acute transplant rejection revisited.
Ponticelli C
J Nephrol; 2012; 25(2):150-8. PubMed ID: 22101676
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
Land WG
Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptors in ischemia-reperfusion injury.
Arumugam TV; Okun E; Tang SC; Thundyil J; Taylor SM; Woodruff TM
Shock; 2009 Jul; 32(1):4-16. PubMed ID: 19008778
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors in transplantation: sensing and reacting to injury.
Leventhal JS; Schröppel B
Kidney Int; 2012 May; 81(9):826-32. PubMed ID: 22297675
[TBL] [Abstract][Full Text] [Related]
32. TLR4 activation mediates kidney ischemia/reperfusion injury.
Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
[TBL] [Abstract][Full Text] [Related]
33. Innate immunity and its role in type 1 diabetes.
Zipris D
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):326-31. PubMed ID: 18594272
[TBL] [Abstract][Full Text] [Related]
34. Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney.
Denecke C; Tullius SG
Prog Urol; 2014 Jun; 24 Suppl 1():S13-9. PubMed ID: 24950927
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor and RIG-I-like receptor signaling.
Kawai T; Akira S
Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor expression in patients with renal allograft dysfunction.
Kwon J; Park J; Lee D; Kim YS; Jeong HJ
Transplant Proc; 2008 Dec; 40(10):3479-80. PubMed ID: 19100417
[TBL] [Abstract][Full Text] [Related]
37. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.2 Chronic graft dysfunction. Immunological factors (alloimmunity).
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():8-11. PubMed ID: 12091618
[TBL] [Abstract][Full Text] [Related]
38. Intragraft Toll-like receptor profiling in acute renal allograft rejection.
Dessing MC; Bemelman FJ; Claessen N; Ten Berge IJ; Florquin S; Leemans JC
Nephrol Dial Transplant; 2010 Dec; 25(12):4087-92. PubMed ID: 20876367
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors-related genes in kidney transplant patients with chronic allograft nephropathy and acute rejection.
Nogueira E; Ponciano VC; Naka EL; Marques GD; Cenedeze MA; Câmara NO; Pacheco-Silva A
Int Immunopharmacol; 2009 Jun; 9(6):673-6. PubMed ID: 19105982
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor signaling and atherosclerosis.
Michelsen KS; Arditi M
Curr Opin Hematol; 2006 May; 13(3):163-8. PubMed ID: 16567960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
